SLK is a ~40kDa humanized nanobody consisting of three domains that binds interleukin-17A (IL-17A), IL-17F, and human serum albumin. It has a unique mechanism of action that inhibits the inflammatory cytokines IL-17A and IL-17F, which are implicated in several autoimmune and inflammatory diseases. U...